Arthur G. C.
- Country
- France
- Department
- n/a
Research Overview
- Safety, Tolerability, and Anti-tumor Activity of HER3-DXd Monotherapy and Combinations in Advanced Breast Cancer Post-Trastuzumab Deruxtecan Progression
- Phase Ib/II Study of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine in HER2+ Metastatic Breast and Gastroesophageal Adenocarcinomas
- Influence of patient’s morphological characteristics on pharmacokinetic and toxicity of trastuzumab-deruxtecan administered for metastatic breast cancers (TDXdose)
Data & Insights
Has run more than one trial at 25 of 72 partner sites.
Specializations
Hematologic Malignancies
Arthur GÉRAUD-CRÉMIEUX is involved in acute myeloid leukemia, myelodysplastic syndromes, and other myeloid neoplasms, with additional interest in relapsed and refractory acute leukemia and high-risk blood cancers.
- Acute myeloid leukemia
- Myelodysplastic syndromes
- Relapsed/refractory leukemia
- Myelofibrosis
His clinical research also extends to lymphoid malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia.
Breast Cancer
His work includes a broad range of breast cancer settings, especially HER2-negative breast cancer, hormone receptor-positive disease, and triple-negative breast cancer, across both early and advanced stages.
- Hormone receptor-positive breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer
- Metastatic breast cancer
He is also engaged in studies addressing HER2-low disease, early breast cancer, and biomarker-defined breast cancer populations.
Genitourinary Oncology
Arthur GÉRAUD-CRÉMIEUX has active clinical interests in prostate cancer, renal cell carcinoma, and urothelial carcinoma, with attention to both localized and metastatic disease.
- Prostate cancer
- Renal cell carcinoma
- Urothelial carcinoma
- Bladder cancer
His portfolio also includes high-risk prostate cancer, non-muscle-invasive bladder cancer, and advanced kidney cancer subtypes.
Gastrointestinal and Hepatobiliary Cancers
His research covers major gastrointestinal cancers, including colorectal cancer, gastric cancer, pancreatic cancer, and biliary tract cancer.
- Colorectal cancer
- Gastric and gastroesophageal junction cancer
- Pancreatic ductal adenocarcinoma
- Hepatocellular carcinoma
He is also involved in neuroendocrine neoplasms and other advanced digestive tract malignancies with limited treatment options.
Rare Solid Tumors and Cellular Therapy
Arthur GÉRAUD-CRÉMIEUX is engaged in research on soft tissue sarcoma, ovarian cancer, endometrial cancer, and selected rare solid tumors, including biomarker-defined advanced malignancies.
- Soft tissue sarcoma
- Ovarian cancer
- Endometrial cancer
- Advanced solid tumors
His clinical interests also include cell therapy, immune-based treatment, and targeted therapies for difficult-to-treat advanced cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.